Publications
- Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?2008 | Second Faculty of Medicine
- CD44 and CD27 delineate B-precursor stages with different recombination status and with an uneven distribution in nonmalignant and malignant hematopoiesis2008 | Second Faculty of Medicine
- TEL/AML1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL2005 | Second Faculty of Medicine
- TEL/AML1 and immunoreceptor gene rearrangements - which comes first?2005 | Second Faculty of Medicine
- Is TEL/AML1 fusion gene appropriate marker for minimal residual disease monitoring in children with acute lymphoblastic leukaemia?2004 | Second Faculty of Medicine
- Molecular Screening in ALK-Positive Anaplastic Large Cell Lymphoma: ALK Analysis, NGS Fusion Gene Detection, and T-cell Receptor Immunoprofiling2024 | Second Faculty of Medicine, Third Faculty of Medicine
- Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–20202023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- IL-17 driven induction of Paneth cell antimicrobial functions protects the host from microbiota dysbiosis and inflammation in the ileum2023 | Second Faculty of Medicine, Faculty of Science
- Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy2023 | First Faculty of Medicine, Second Faculty of Medicine
- NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on MRD-based protocol2023 | Second Faculty of Medicine
Loading network view...